Alcor, Water Street partner to accelerate expansion

Create PDF

April 2022—Alcor Scientific is partnering with Chicago-based health care investor Water Street Healthcare Partners. Water Street will invest in Alcor’s research and development initiatives, product portfolio, and international expansion. Alcor has appointed Jim Post as chief executive officer to lead its next phase of innovation and growth.

Based in Smithfield, RI, Alcor offers a fully automated solution for erythrocyte sedimentation rate testing, which measures inflammation for a range of clinical purposes including diagnosing and monitoring autoimmune diseases, cancer, and infections.